Establishment Labs (ESTA) Competitors $35.88 -1.78 (-4.73%) Closing price 04:00 PM EasternExtended Trading$36.60 +0.72 (+2.02%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. BLCO, TMDX, SLNO, PRCT, NVST, LIVN, ENOV, NVCR, LMAT, and SSIIShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), Envista (NVST), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), LeMaitre Vascular (LMAT), and SS Innovations International (SSII). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Bausch + Lomb TransMedics Group Soleno Therapeutics PROCEPT BioRobotics Envista LivaNova Enovis NovoCure LeMaitre Vascular SS Innovations International Establishment Labs (NASDAQ:ESTA) and Bausch + Lomb (NYSE:BLCO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations, community ranking and profitability. Does the media refer more to ESTA or BLCO? In the previous week, Establishment Labs had 9 more articles in the media than Bausch + Lomb. MarketBeat recorded 15 mentions for Establishment Labs and 6 mentions for Bausch + Lomb. Establishment Labs' average media sentiment score of 1.06 beat Bausch + Lomb's score of 0.87 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 9 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bausch + Lomb 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ESTA or BLCO more profitable? Bausch + Lomb has a net margin of -6.62% compared to Establishment Labs' net margin of -46.13%. Bausch + Lomb's return on equity of 3.35% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% Bausch + Lomb -6.62%3.35%1.66% Which has more risk & volatility, ESTA or BLCO? Establishment Labs has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Bausch + Lomb has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Does the MarketBeat Community favor ESTA or BLCO? Establishment Labs received 80 more outperform votes than Bausch + Lomb when rated by MarketBeat users. Likewise, 62.37% of users gave Establishment Labs an outperform vote while only 41.00% of users gave Bausch + Lomb an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes12162.37% Underperform Votes7337.63% Bausch + LombOutperform Votes4141.00% Underperform Votes5959.00% Which has better valuation & earnings, ESTA or BLCO? Establishment Labs has higher earnings, but lower revenue than Bausch + Lomb. Establishment Labs is trading at a lower price-to-earnings ratio than Bausch + Lomb, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$170.24M6.17-$78.50M-$3.10-11.72Bausch + Lomb$4.83B0.83-$317M-$1.03-11.02 Do insiders and institutionals believe in ESTA or BLCO? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 11.1% of Establishment Labs shares are held by company insiders. Comparatively, 0.8% of Bausch + Lomb shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer ESTA or BLCO? Establishment Labs currently has a consensus target price of $55.33, indicating a potential upside of 52.32%. Bausch + Lomb has a consensus target price of $15.50, indicating a potential upside of 36.50%. Given Establishment Labs' stronger consensus rating and higher probable upside, research analysts clearly believe Establishment Labs is more favorable than Bausch + Lomb.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Bausch + Lomb 1 Sell rating(s) 7 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.25 SummaryEstablishment Labs beats Bausch + Lomb on 12 of the 18 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04B$9.51B$5.35B$8.38BDividend YieldN/A1.61%5.22%4.10%P/E Ratio-13.9120.8726.8419.71Price / Sales6.0963.84391.39116.98Price / CashN/A19.6738.2534.62Price / Book50.545.056.794.50Net Income-$78.50M$284.66M$3.23B$248.18M7 Day Performance-1.59%-1.23%4.07%1.14%1 Month Performance22.00%4.43%12.52%15.18%1 Year Performance-34.01%-21.30%16.83%6.55% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.8867 of 5 stars$35.88-4.7%$55.33+54.2%-30.3%$1.04B$170.24M-13.91960Positive NewsBLCOBausch + Lomb4.2513 of 5 stars$11.76flat$15.50+31.8%-19.2%$4.16B$4.83B-12.9212,500Gap UpTMDXTransMedics Group1.4381 of 5 stars$122.10+0.4%$126.70+3.8%-10.0%$4.13B$488.23M129.89210Positive NewsSLNOSoleno Therapeutics4.8514 of 5 stars$75.58+0.8%$106.78+41.3%+59.6%$3.81BN/A-22.7730News CoveragePositive NewsPRCTPROCEPT BioRobotics2.9275 of 5 stars$59.29+2.1%$90.00+51.8%-13.9%$3.28B$249.12M-30.40430Positive NewsGap UpNVSTEnvista4.1752 of 5 stars$17.68-3.2%$20.08+13.6%-2.7%$3.00B$2.50B-2.7212,700Positive NewsGap UpLIVNLivaNova3.8004 of 5 stars$43.97-1.0%$59.17+34.6%-26.8%$2.40B$1.28B104.692,900Analyst UpgradeGap UpENOVEnovis3.1864 of 5 stars$35.45-1.7%$58.00+63.6%-32.6%$2.03B$2.15B-16.196,800Gap UpNVCRNovoCure3.6341 of 5 stars$17.96+0.4%$32.83+82.8%-24.3%$2.00B$621.71M-12.831,320Positive NewsLMATLeMaitre Vascular2.5947 of 5 stars$85.96+1.4%$98.14+14.2%+6.8%$1.94B$226.26M46.97490Insider TradeSSIISS Innovations InternationalN/A$9.74-1.0%N/AN/A$1.89B$20.65M0.004 Related Companies and Tools Related Companies Bausch + Lomb Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives PROCEPT BioRobotics Alternatives Envista Alternatives LivaNova Alternatives Enovis Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives SS Innovations International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ESTA Stock Free ESTA Stock Alerts